Microbiology

  1. The coding capacity of SARS-CoV-2

    1. Yaara Finkel
    2. Orel Mizrahi
    3. Aharon Nachshon
    4. Shira Weingarten-Gabbay
    5. David Morgenstern
    6. Yfat Yahalom-Ronen
    7. Hadas Tamir
    8. Hagit Achdout
    9. Dana Stein
    10. Ofir Israeli
    11. Adi Beth-Din
    12. Sharon Melamed
    13. Shay Weiss
    14. Tomer Israely
    15. Nir Paran
    16. Michal Schwartz
    17. Noam Stern-Ginossar

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. A combined approach of MALDI-TOF mass spectrometry and multivariate analysis as a potential tool for the detection of SARS-CoV-2 virus in nasopharyngeal swabs

    1. María Florencia Rocca
    2. Jonathan Cristian Zintgraff
    3. María Elena Dattero
    4. Leonardo Silva Santos
    5. Martín Ledesma
    6. Carlos Vay
    7. Mónica Prieto
    8. Estefanía Benedetti
    9. Martín Avaro
    10. Mara Russo
    11. Fabiane Manke Nachtigall
    12. Elsa Baumeister

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures

    1. Kenneth H. Dinnon
    2. Sarah R. Leist
    3. Alexandra Schäfer
    4. Caitlin E. Edwards
    5. David R. Martinez
    6. Stephanie A. Montgomery
    7. Ande West
    8. Boyd L. Yount
    9. Yixuan J. Hou
    10. Lily E. Adams
    11. Kendra L. Gully
    12. Ariane J. Brown
    13. Emily Huang
    14. Matthew D. Bryant
    15. Ingrid C. Choong
    16. Jeffrey S. Glenn
    17. Lisa E. Gralinski
    18. Timothy P. Sheahan
    19. Ralph S. Baric

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Coronavirus activates a stem cell-mediated defense mechanism that reactivates dormant tuberculosis: implications in COVID-19 pandemic

    1. Lekhika Pathak
    2. Sukanya Gayan
    3. Bidisha Pal
    4. Joyeeta Talukdar
    5. Seema Bhuyan
    6. Sorra Sandhya
    7. Herman Yeger
    8. Debabrat Baishya
    9. Bikul Das

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine

    1. Marion Plaze
    2. David Attali
    3. Matthieu Prot
    4. Anne-Cécile Petit
    5. Michael Blatzer
    6. Fabien Vinckier
    7. Laurine Levillayer
    8. Florent Perin-Dureau
    9. Arnaud Cachia
    10. Gérard Friedlander
    11. Fabrice Chrétien
    12. Etienne Simon-Loriere
    13. Raphaël Gaillard

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Neutralization of SARS-CoV-2 by destruction of the prefusion Spike

    1. Jiandong Huo
    2. Yuguang Zhao
    3. Jingshan Ren
    4. Daming Zhou
    5. Helen ME Duyvesteyn
    6. Helen M Ginn
    7. Loic Carrique
    8. Tomas Malinauskas
    9. Reinis R Ruza
    10. Pranav NM Shah
    11. Tiong Kit Tan
    12. Pramila Rijal
    13. Naomi Coombes
    14. Kevin Bewley
    15. Julika Radecke
    16. Neil G Paterson
    17. Piyasa Supasa
    18. Juthathip Mongkolsapaya
    19. Gavin R Screaton
    20. Miles Carroll
    21. Alain Townsend
    22. Elizabeth E Fry
    23. Raymond J Owens
    24. David I Stuart

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Multiple SARS-CoV-2 introductions shaped the early outbreak in Central Eastern Europe: comparing Hungarian data to a worldwide sequence data-matrix

    1. Gábor Kemenesi
    2. Safia Zeghbib
    3. Balázs A Somogyi
    4. Gábor Endre Tóth
    5. Krisztián Bányai
    6. Norbert Solymosi
    7. Peter M Szabo
    8. István Szabó
    9. Ádám Bálint
    10. Péter Urbán
    11. Róbert Herczeg
    12. Attila Gyenesei
    13. Ágnes Nagy
    14. Csaba István Pereszlényi
    15. Gergely Csaba Babinszky
    16. Gábor Dudás
    17. Gabriella Terhes
    18. Viktor Zöldi
    19. Róbert Lovas
    20. Szabolcs Tenczer
    21. László Kornya
    22. Ferenc Jakab

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2–Priming Protease TMPRSS2

    1. Nurit P Azouz
    2. Andrea Klingler
    3. Victoria Callahan
    4. Ivan Akhrymuk
    5. Katarina Elez
    6. Lluís Raich
    7. Brandon Henry
    8. Justin Benoit
    9. Stefanie Benoit
    10. Frank Noé
    11. Kylene Kehn-Hall
    12. Marc Rothenberg

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Selectomic and Evolvability Analyses of the Highly Pathogenic Betacoronaviruses SARS-CoV-2, SARS-CoV, and MERS-CoV

    1. Meghan May
    2. Bahman Rostama
    3. Ryan F. Relich

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Identification of Candidate COVID-19 Therapeutics using hPSC-derived Lung Organoids

    1. Yuling Han
    2. Liuliu Yang
    3. Xiaohua Duan
    4. Fuyu Duan
    5. Benjamin E. Nilsson-Payant
    6. Tomer M. Yaron
    7. Pengfei Wang
    8. Xuming Tang
    9. Tuo Zhang
    10. Zeping Zhao
    11. Yaron Bram
    12. David Redmond
    13. Sean Houghton
    14. Duc Nguyen
    15. Dong Xu
    16. Xing Wang
    17. Skyler Uhl
    18. Yaoxing Huang
    19. Jared L. Johnson
    20. Jenny Xiang
    21. Hui Wang
    22. Fong Cheng Pan
    23. Lewis C. Cantley
    24. Benjamin R. tenOever
    25. David D. Ho
    26. Todd Evans
    27. Robert E. Schwartz
    28. Huanhuan Joyce Chen
    29. Shuibing Chen

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 65 of 251 Next